20 results
8-K
EX-10.1
CGTX
Cognition Therapeutics Inc
1 May 23
Departure of Directors or Certain Officers
7:30am
policies of the Company in effect from time to time, including (without limitation) policies regarding ethics, personal conduct, stock ownership
424B4
CGTX
Cognition Therapeutics Inc
14 Nov 22
Prospectus supplement with pricing info
6:02am
to the FDA of an IND, which must become effective before human clinical trials may begin;
approval by an independent IRB ethics committee, either centralized
DRS
t984kl7ytr3jnrmm 8xz
20 Oct 22
Draft registration statement
12:00am
DEF 14A
nvfyv
25 Apr 22
Definitive proxy
5:28pm
10-K
dfwqzr5v3
30 Mar 22
Annual report
7:40am
10-Q
naky25fmg fi
17 Nov 21
Quarterly report
5:15pm
424B4
4wro4zx xj
12 Oct 21
Prospectus supplement with pricing info
4:11pm
S-1
tunkhzer2v
19 Jul 21
IPO registration
7:02am
DRS/A
kzvuvvzsm
23 Jun 21
Draft registration statement (amended)
12:00am
DRS
c4wq bc62
7 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next